Shares of Hemostemix Inc. (CVE:HEM – Get Free Report) crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$0.10 and traded as low as C$0.08. Hemostemix shares last traded at C$0.08, with a volume of 42,982 shares traded.
Hemostemix Trading Down 5.9%
The business’s 50-day simple moving average is C$0.10 and its two-hundred day simple moving average is C$0.11. The firm has a market capitalization of C$14.48 million, a price-to-earnings ratio of -2.96 and a beta of 1.03. The company has a quick ratio of 0.48, a current ratio of 0.04 and a debt-to-equity ratio of -55.07.
About Hemostemix
Hemostemix Inc, a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia.
Read More
- Five stocks we like better than Hemostemix
- How to Choose Top Rated Stocks
- Why Gold Loves Trump as Much as Trump Loves Gold
- How to Read Stock Charts for Beginners
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
- How to Use the MarketBeat Excel Dividend Calculator
- Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It
Receive News & Ratings for Hemostemix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemostemix and related companies with MarketBeat.com's FREE daily email newsletter.
